Risk Factors for Nontuberculous Mycobacteria Infections in Solid Organ Transplant Recipients: A Multinational Case-Control Study
- 26 July 2022
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 76 (3) , e995-e1003
Abstract
Risk factors for nontuberculous mycobacteria (NTM) infections after solid organ transplant (SOT) are not well characterized. Here we aimed to describe these factors. Retrospective, multinational, 1:2 matched case-control study that included SOT recipients ≥12 years old diagnosed with NTM infection from 1 January 2008 to 31 December 2018. Controls were matched on transplanted organ, NTM treatment center, and post-transplant survival greater than or equal to the time to NTM diagnosis. Logistic regression on matched pairs was used to assess associations between risk factors and NTM infections. Analyses included 85 cases and 169 controls (59% male, 88% White, median age at time of SOT of 54 years [interquartile range {IQR} 40–62]). NTM infection occurred in kidney (42%), lung (35%), heart and liver (11% each), and pancreas transplant recipients (1%). Median time from transplant to infection was 21.6 months (IQR 5.3–55.2). Most underlying comorbidities were evenly distributed between groups; however, cases were older at the time of NTM diagnosis, more frequently on systemic corticosteroids and had a lower lymphocyte count (all P < .05). In the multivariable model, older age at transplant (adjusted odds ratio [aOR] 1.04; 95 confidence interval [CI], 1.01–1.07), hospital admission within 90 days (aOR, 3.14; 95% CI, 1.41–6.98), receipt of antifungals (aOR, 5.35; 95% CI, 1.7–16.91), and lymphocyte-specific antibodies (aOR, 7.73; 95% CI, 1.07–56.14), were associated with NTM infection. Risk of NTM infection in SOT recipients was associated with older age at SOT, prior hospital admission, receipt of antifungals or lymphocyte-specific antibodies. NTM infection should be considered in SOT patients with these risk factors.Keywords
Funding Information
- Swiss National Science Foundation
- School of Medicine, Washington University in St. Louis
This publication has 33 references indexed in Scilit:
- Non‐tuberculous mycobacterial infection among lung transplant recipients: a 15‐year cohort studyTransplant Infectious Disease, 2012
- Prevalence of Nontuberculous Mycobacterial Lung Disease in U.S. Medicare BeneficiariesAmerican Journal of Respiratory and Critical Care Medicine, 2012
- Non-tuberculous mycobacterium infection after lung transplantation is associated with increased mortalityThe Journal of Heart and Lung Transplantation, 2011
- Nontuberculous Pulmonary Mycobacteriosis in Denmark: Incidence and Prognostic FactorsAmerican Journal of Respiratory and Critical Care Medicine, 2010
- Nontuberculous Mycobacterial Disease Prevalence and Risk Factors: A Changing EpidemiologyClinical Infectious Diseases, 2009
- Pretransplant lymphocyte count predicts the incidence of infection during the first two years after liver transplantationLiver Transplantation, 2009
- An Official ATS/IDSA Statement: Diagnosis, Treatment, and Prevention of Nontuberculous Mycobacterial DiseasesAmerican Journal of Respiratory and Critical Care Medicine, 2007
- Clinical, Microbiological, and Immunological Characteristics in HIV-Infected Subjects at Risk for Disseminated Mycobacterium avium Complex Disease: An AACTG StudyAIDS Research and Human Retroviruses, 2005
- Nontuberculous Mycobacterial Infection in Hematopoietic Stem Cell and Solid Organ Transplant RecipientsClinical Infectious Diseases, 2004
- Infections Due to Nontuberculous Mycobacteria in Kidney, Heart, and Liver Transplant RecipientsClinical Infectious Diseases, 1994